We investigated the effect of changes to state
AIDS Drug Assistance Programs (ADAP) policies, which govern access to
antiretroviral therapy (ART), on clinical and economic outcomes among
low-income people living with HIV/AIDS.
Retrospective analyses of ART access
were conducted on state ADAP policies, using data from ADAP Monitoring Reports
and Kaiser Family Foundation from 2006 to 2010. We found stricter eligibility
requirements reduce the number of HIV-positive individuals with ART access
through ADAP, and decreased ART use increases mortality by 2.67
quality-adjusted life years (QALYs) per beneficiary. If the ADAP income
eligibility cutoff were decreased by 50 percentage points in each state, 4,626
individuals would lose ART access nationwide. Based on a $22,143 cost/QALY,
this policy would save $274 million in health care expenditures (2012 dollars),
but result in 12,352 QALYs lost, valued at $1.2 billion.
Therefore, states
should exercise caution in restricting programs that increase ART access for
low-income people living with HIV/AIDS.
Purchase full article at: http://goo.gl/iB96wF
By:
- 1Precision Health Economics, Los Angeles, CA, USA julia.snider@pheconomics.com.
- 2University of Southern California, Los Angeles, CA, USA.
- 3Bristol-Myers Squibb, Plainsboro, NJ, USA.
- 4AbbVie, Chicago, IL, USA.
- 5Precision Health Economics, Los Angeles, CA, USA.
More at: https://twitter.com/hiv_insight
No comments:
Post a Comment